Your browser doesn't support javascript.
loading
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update.
Brannagan, Thomas H; Coelho, Teresa; Wang, Annabel K; Polydefkis, Michael J; Dyck, Peter J; Berk, John L; Drachman, Brian; Gorevic, Peter; Whelan, Carol; Conceição, Isabel; Plante-Bordeneuve, Violaine; Merlini, Giampaolo; Obici, Laura; Plana, Josep Maria Campistol; Gamez, Josep; Kristen, Arnt V; Mazzeo, Anna; Gentile, Luca; Narayana, Arvind; Olugemo, Kemi; Aquino, Peter; Benson, Merrill D; Gertz, Morie.
Affiliation
  • Brannagan TH; Department of Neurology, Columbia University Medical Center, 710 West 168th Street, New York, NY, 10032, USA. tb2325@cumc.columbia.edu.
  • Coelho T; Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Wang AK; Neuromuscular Diagnostic Laboratory, University of California, Irvine, Orange, CA, USA.
  • Polydefkis MJ; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
  • Dyck PJ; Neurology and General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Berk JL; Amyloid Clinic, Boston University, Boston, MA, USA.
  • Drachman B; Cardiovascular Medicine, Penn Presbyterian Medical Center, Philadelphia, PA, USA.
  • Gorevic P; Department of Rheumatology, Mount Sinai Medical Center, New York, NY, USA.
  • Whelan C; Cardiology, National Amyloidosis Centre, Royal Free Hospital, London, UK.
  • Conceição I; Department of Neurology, CHULN, Hospital Santa Maria and Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Plante-Bordeneuve V; CHU Henri Mondor, Creteil, France.
  • Merlini G; Amyloidosis Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Obici L; Amyloidosis Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Plana JMC; Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Gamez J; Neurology Department, GMA Clinic, Autonomous University of Barcelona and European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Barcelona, Spain.
  • Kristen AV; Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany.
  • Mazzeo A; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Gentile L; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Narayana A; Akcea Therapeutics, Boston, MA, USA.
  • Olugemo K; Akcea Therapeutics, Boston, MA, USA.
  • Aquino P; Akcea Therapeutics, Boston, MA, USA.
  • Benson MD; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Gertz M; Neurology and General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
J Neurol ; 269(12): 6416-6427, 2022 Dec.
Article in En | MEDLINE | ID: mdl-35908242
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligonucleotides / Amyloid Neuropathies, Familial Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Neurol Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligonucleotides / Amyloid Neuropathies, Familial Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Neurol Year: 2022 Type: Article Affiliation country: United States